Literature DB >> 24992422

The safety and efficacy of bariatric surgery for obese, wheelchair bound patients.

G J Williams1, P A Georgiou, D M Cocker, G Bonanomi, J Smellie, E Efthimiou.   

Abstract

INTRODUCTION: The aim of this study was to evaluate outcomes of bariatric surgery performed in order to improve mobility in patients with severe mobility limitations.
METHODS: Patients with severe mobility impairment (wheelchair bound) who underwent laparoscopic Roux-en-Y gastric bypass (LRYGB) or laparoscopic adjustable gastric banding (LAGB) surgery to improve their mobility were included in this study. Patients were identified between July 2009 and October 2011 using an electronic prospective bariatric database. Mobility was assessed by questionnaire during clinic follow-up appointments.
RESULTS: Fifteen patients (11 female, 4 male) with a mean age of 48 years (range: 26-71 years) and a mean body mass index of 46 kg/m(2) (range: 33-54 kg/m(2)) were included. Seven patients (47%) underwent LAGB and eight (53%) LRYGB. The aetiologies of mobility impairment included advanced osteoarthritis (n=6), spinal conditions (n=4), severe bilateral leg oedema and ulceration (n=2), advanced rheumatoid arthritis (n=2) and traumatic paraplegia (n=1). The mean length of hospital stay was 3.8 days. There was no mortality. One patient was lost to follow-up. Of the remaining 14 patients, the mean excess weight loss percentage at a mean of 18.5 months postoperatively was 48% (68% for LRYGB, 20 months; 29% for LAGB, 17 months). Ten patients reported improved mobility. Reduced pain, improved independence and ability to transfer were most commonly cited. Four patients reported no improvement in mobility (three LAGB patients, one LRYGB patient).
CONCLUSIONS: Bariatric surgery can safely improve mobility and quality of life in obese patients with severe mobility impairment. Our paper supports the idea that severe mobility impairment should be considered an indication for bariatric surgery in selected patients. LRYGB demonstrated better weight loss and mobility improvement than LAGB. Larger studies are required to establish robust selection criteria for surgery in this group.

Entities:  

Mesh:

Year:  2014        PMID: 24992422      PMCID: PMC4473935          DOI: 10.1308/003588414X13946184901083

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  20 in total

1.  Exercise, self-efficacy, and mobility performance in overweight and obese older adults with knee osteoarthritis.

Authors:  Brian C Focht; W Jack Rejeski; Walter T Ambrosius; Jeffrey A Katula; Stephen P Messier
Journal:  Arthritis Rheum       Date:  2005-10-15

2.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.

Authors:  Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel
Journal:  N Engl J Med       Date:  2004-12-23       Impact factor: 91.245

3.  Assessment of obesity-related comorbidities: a novel scheme for evaluating bariatric surgical patients.

Authors:  Mohamed R Ali; Mary Beth Maguire; Bruce M Wolfe
Journal:  J Am Coll Surg       Date:  2005-11-18       Impact factor: 6.113

Review 4.  Bariatric surgical outcomes.

Authors:  Mohamed R Ali; William D Fuller; Michael P Choi; Bruce M Wolfe
Journal:  Surg Clin North Am       Date:  2005-08       Impact factor: 2.741

5.  Intensive weight loss program improves physical function in older obese adults with knee osteoarthritis.

Authors:  Gary D Miller; Barbara J Nicklas; Cralen Davis; Richard F Loeser; Leon Lenchik; Stephen P Messier
Journal:  Obesity (Silver Spring)       Date:  2006-07       Impact factor: 5.002

6.  Weight gain after short- and long-limb gastric bypass in patients followed for longer than 10 years.

Authors:  Nicolas V Christou; Didier Look; Lloyd D Maclean
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

7.  Efficacy of gastric bypass in the treatment of obesity-related comorbidities.

Authors:  LeeAnn Peluso; Vincent W Vanek
Journal:  Nutr Clin Pract       Date:  2007-02       Impact factor: 3.080

8.  Weight loss: the treatment of choice for knee osteoarthritis? A randomized trial.

Authors:  R Christensen; A Astrup; H Bliddal
Journal:  Osteoarthritis Cartilage       Date:  2005-01       Impact factor: 6.576

9.  Weight loss reduces knee-joint loads in overweight and obese older adults with knee osteoarthritis.

Authors:  Stephen P Messier; David J Gutekunst; Cralen Davis; Paul DeVita
Journal:  Arthritis Rheum       Date:  2005-07

Review 10.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.

Authors:  Andrew G Renehan; Margaret Tyson; Matthias Egger; Richard F Heller; Marcel Zwahlen
Journal:  Lancet       Date:  2008-02-16       Impact factor: 79.321

View more
  4 in total

1.  Identification and Management of Cardiometabolic Risk after Spinal Cord Injury.

Authors:  Mark S Nash; Suzanne L Groah; David R Gater; Trevor A Dyson-Hudson; Jesse A Lieberman; Jonathan Myers; Sunil Sabharwal; Allen J Taylor
Journal:  J Spinal Cord Med       Date:  2019-06-10       Impact factor: 1.985

2.  Identification and Management of Cardiometabolic Risk after Spinal Cord Injury: Clinical Practice Guideline for Health Care Providers.

Authors:  Mark S Nash; Suzanne L Groah; David R Gater; Trevor A Dyson-Hudson; Jesse A Lieberman; Jonathan Myers; Sunil Sabharwal; Allen J Taylor
Journal:  Top Spinal Cord Inj Rehabil       Date:  2018

3.  Comparative Outcomes of Bariatric Surgery in Patients with Impaired Mobility and Ambulatory Population.

Authors:  Gautam Sharma; Zubaidah Nor-Hanipah; Ivy N Haskins; Suriya Punchai; Andrew T Strong; Chao Tu; John H Rodriguez; Phillip R Schauer; Matthew Kroh
Journal:  Obes Surg       Date:  2018-07       Impact factor: 4.129

Review 4.  Guideline Approaches for Cardioendocrine Disease Surveillance and Treatment Following Spinal Cord Injury.

Authors:  Mark S Nash; James L J Bilzon
Journal:  Curr Phys Med Rehabil Rep       Date:  2018-11-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.